I agree the Resolute review muddies the waters a bit (a lot) but you don't under play the outlook because there might be a deal coming.
In the normal world you talk it up to get the best price possible.
In the absence of a deal if the trajectory of revenue from the distributor model continues, that can underpin the business going forward. Then you get the big projects coming in, albeit sporadically, to drive the growth. Manufacturing in China is set, Wyoming is ready to advance as a second source of product. The company must make hay in this Nthn Hemisphere summer as water bodies warm up and turn ugly.
I'm punting a couple of large deals will land this quarter or next.
- Forums
- ASX - By Stock
- PET
- Ann: Appendix 4C Quarterly (Q2 2023) and Business Update
PET
phoslock environmental technologies limited
Add to My Watchlist
0.00%
!
2.5¢

Ann: Appendix 4C Quarterly (Q2 2023) and Business Update, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online